Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Health Canada has approved LYVDELZI (seladelpar) for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic ...
About eight million people in the UK take some sort of antidepressant for mental health conditions such as depression and ...
Pfizer's BRAFTOVI + MEKTOVI Shows Sustained Long-Term Survival In Patients With Advanced Lung Cancer
Pfizer Inc. (NYSE: PFE) today announced updated follow-up results from the single-arm Phase 2 PHAROS trial evaluating BRAFTOVI® (encorafenib ...
VCN-01 expanded mPDAC data from VIRAGE Phase 2b trial to be presented at ESMO 2025 -- SYN-004 Interim blinded safety and pharmacokinetic data ...
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.
Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the strength ...
First and only therapy FDA approved in both R/R acute myeloid leukemia (AML) with an NPM1 mutation and R/R acute leukemia with a KMT2A ...
PFAS are a group of man-made chemicals linked to serious health risks. Here’s how to reduce your exposure to PFAS in water, ...
While our genes play a key role in determining our cognitive aging, our general health also plays a big factor.
Below are seven nutrients frequently under-recognized, their signs, challenges to absorption, and how to address them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback